Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer

NCT02403531 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Docetaxel
DRUG: Cisplatin
RADIATION: Radiotherapy

Sponsor

Mian XI